Skip to content

Cancer immunotherapy - Category Home

Cancer immunotherapy - Topics

Tumor mutational burden: why more mutations can mean a better immunotherapy response CAR-T therapy: how a patient's own T cells are engineered to fight cancer Why some cancers are called hot tumors and others cold Steroids for immune side effects: do they cancel out the cancer benefit? Cancer vaccines: why they are not like ordinary vaccines CTLA-4 versus PD-1 blockade: two different brakes on the immune system Adoptive cell transfer beyond CAR-T: tumor-infiltrating lymphocytes How PD-1 checkpoint inhibitors release the brakes on T cells Bispecific antibodies: pulling T cells and tumor cells together Cytokine therapy: what interleukin-2 does and why it is rarely used now Nivolumab plus ipilimumab: why double immunotherapy raises side effect risk Pseudoprogression: when scans look worse before they look better on immunotherapy Why immunotherapy takes weeks before any effect shows up Thyroid problems after starting immunotherapy and how they get monitored What is the tumor microenvironment and why does it shape treatment response? Immune checkpoint pneumonitis: the side effect that looks like a chest infection Which cancers actually respond to checkpoint inhibitor immunotherapy? Why has cancer research shifted from killing tumors to understanding the immune system? Immune-related colitis: why diarrhea during immunotherapy needs urgent attention Immunotherapy combined with chemotherapy: why the two are given together Can immunotherapy be restarted after a serious immune-related adverse event? How do tumors exhaust the immune cells sent to attack them? Immunotherapy for advanced melanoma: what long-term remission looks like How long should immunotherapy continue when scans look clean? Can palliative treatment continue while I am on immunotherapy? How much does cancer immunotherapy cost and what insurance covers